4:32 PM ET
Form 4
Insider Buying
NovaBridge Biosciences Chief Commercial Officer Mark Arnold Hagler Buys $85.9K of Stock
Mark Arnold Hagler, Chief Commercial Officer, bought 230,000 shares of NovaBridge Biosciences at $0.343 to $0.381 a share (average $0.3734) in 2 transactions, worth $85.9K in total between Nov 17, 2026 and Nov 18, 2026. Shares held after the trade: 460,000 (+66.7%).
- Value
- $85.9K
- Shares
- 230,000
- Average price
- $0.3734
- Role
- Chief Commercial Officer
- Holding change
- +66.7%
- Trade date
- Nov 17, 2026 to Nov 18, 2026